Literature DB >> 189890

Malignant mixed tumor of salivary origin: a clinicopathologic study of 146 cases.

R H Spiro, A G Huvos, E W Strong.   

Abstract

A 30-year Memorial Hospital experience with 146 patients with malignant mixed tumor is reviewed. These comprised 5% of 2,743 patients who were treated for salivary neoplasms from 1939 through 1968. The tumors arose in the parotid gland in 108 patients, submaxillary gland in 23 patients, mucus or so-called minor salivary glands in 16 patients, and sublingual gland in one. In terms of our total experience, 11% of all submaxillary tumors proved to be of the malignant mixed variety as compared to 6% of parotid tumors and 3% of minor salivary tumors, respectively. Seventy-one patients (48%) had previously received therapy elsewhere. Results of treatment are presented and the factors which influenced the results are discussed.

Entities:  

Mesh:

Year:  1977        PMID: 189890     DOI: 10.1002/1097-0142(197702)39:2<388::aid-cncr2820390204>3.0.co;2-d

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  27 in total

1.  Oncocytic carcinoma ex pleomorphic adenoma.

Authors:  Demet Etit; Ayca Tan; Umit Bayol; Deniz Altinel; Suheyla Cumurcu; Ibrahim Cukurova
Journal:  Head Neck Pathol       Date:  2009-12-10

2.  Twice-a-day treatment in the radiotherapeutic management of malignant mixed tumor of the parotid gland: A case report.

Authors:  A L Goldson; G A Alexander; H L Martin; J E White
Journal:  J Natl Med Assoc       Date:  1978-12       Impact factor: 1.798

3.  Malignant mixed tumour. A salivary gland tumour showing both carcinomatous and sarcomatous features.

Authors:  H Hellquist; L Michaels
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

Review 4.  NUT Midline Carcinoma of the Sublingual Gland: Clinical Presentation and Review.

Authors:  Nolan B Seim; Ramez H W Philips; Lynn Schoenfield; Theodoros N Teknos; James W Rocco; Amit Agrawal; Enver Ozer; Ricardo L Carrau; Stephen Y Kang; Matthew O Old
Journal:  Head Neck Pathol       Date:  2017-03-27

5.  An epidemiological survey of lacrimal fossa lesions in Japan: number of patients and their sex ratio by pathological diagnosis.

Authors: 
Journal:  Jpn J Ophthalmol       Date:  2005 Sep-Oct       Impact factor: 2.447

6.  Increased SOX2 expression in salivary gland carcinoma ex pleomorphic adenoma progression: an association with adverse outcome.

Authors:  Bruno Tavares Sedassari; Maria Fernanda Setúbal Destro Rodrigues; Thalita Santana Conceição; Fernanda Viviane Mariano; Venâncio Avancini Ferreira Alves; Fábio Daumas Nunes; Albina Altemani; Suzana Cantanhede Orsini Machado de Sousa
Journal:  Virchows Arch       Date:  2017-08-25       Impact factor: 4.064

7.  Malignant mixed tumor of the lacrimal gland. A clinicopathologic report of two unusual cases.

Authors:  H Witschel; L E Zimmerman
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1981

Review 8.  Carcinoma ex pleomorphic adenoma, with particular emphasis on early lesions.

Authors:  Silvana Di Palma
Journal:  Head Neck Pathol       Date:  2013-07-03

9.  Intracapsular (in situ) carcinoma ex pleomorphic adenoma with unusual clinical and histological features.

Authors:  Rajesh Logasundaram; Himan Amarawickrama; Don Premachandra; Henrik Hellquist
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-02-21       Impact factor: 2.503

10.  Adenoid cystic carcinoma ex pleomorphic adenoma of the parotid gland.

Authors:  Fumio Ide; Kenji Mishima; Hiroyuki Yamada; Ichiro Saito
Journal:  Head Neck Pathol       Date:  2009-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.